Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis

Published:2018-03 Issue:3 Volume:40 Page:480-494.e23
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Maiese Eric M.,Ainsworth Claire,Le Moine Jean-Gabriel,Ahdesmäki Outi,Bell Judith,Hawe Emma

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference60 articles.

1. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation;Durie;Hematol J,2003

2. Current treatment landscape for relapsed and/or refractory multiple myeloma;Dimopoulos;Nat Rev Clin Oncol,2015

3. Novel agents in the treatment of multiple myeloma: a review about the future;Naymagon;J Hematol Oncol,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data;Current Problems in Cancer;2024-06

2. Cost-effectiveness and budget impact analysis of Daratumumab, Lenalidomide and dexamethasone for relapsed-refractory multiple myeloma;Cost Effectiveness and Resource Allocation;2024-02-28

3. Effect modification in network meta-analyses for relapsed/refractory multiple myeloma: systematic review and meta-analysis;BMJ Open;2023-08

4. Network meta-analysis of efficacy of ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma;Hematology;2023-01-06

5. Efficacy and safety of carfilzomib for the treatment of multiple myeloma: An overview of systematic reviews;Critical Reviews in Oncology/Hematology;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3